Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

To Evaluate the Feasibility of Collecting Duodenal Fluid With SIMBA Capsules

NCT: NCT06708832 · COMPLETED

NCT IDNCT06708832
StatusCOMPLETED
Start Date2025-06-10
Completion2025-07-16
SponsorVanessa Stadlbauer-Koellner, MD (OTHER)
First posted
Last updated

Brief Summary

In this study, the feasibility to use SIMBA (Small Intestinal MicroBiome Aspiration) capsules to collect small intestinal microbiome and metabolome information will be evaluated in patients with liver cirrhosis. Furthermore, the comparability oral, fecal and small intestinal microbiome and metabolome composition based on similarities and differences in 16s sequencing data and NMR metabolomics data will be evaluated.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑